ABL Attending Annual Meeting of the American Society of Gene and Cell Therapy

ABL Attending Annual Meeting of the American Society of Gene and Cell Therapy

  • May 13-16, 2015
  • New Orleans, LA

New Orleans, LA – May 13, 2015 – ABL will attend the 18th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT).  The meeting will be held in New Orleans on May 13-16.  This meeting will bring together the world’s top researchers and clinicians in the field for education, presentations, networking, and social events.  There will be 19 scientific symposia covering a wide range of topics, including:

  • Cancer Immunotherapies
  • Clinical Gene and Cell Therapy
  • Nanomaterials
  • Orphan Diseases
  • Adenovirus Vectors
  • Policy and Funding Issues
  • Gene Editing and Gene Regulation
  • Biomanufacturing

Visit with ABL staff at booth number 113 or contact us to schedule a meeting during the conference.

About ABL, Inc.

ABL, Inc. is a global biomedical contract research and manufacturing organization dedicated to advancing vaccines, therapeutics and other biologic products. ABL has extensive experience working with diverse organizations, including the U.S. Government, biopharmaceutical companies and academic entities. Notable contract manufacturing services include process and assay development, cGMP biologics manufacturing of bulk drug substance, cGMP aseptic fill and finish of drug product, and QC analytics in the U.S. and Europe. ABL also maintains U.S. and European immunological and molecular laboratories to support preclinical and GCLP clinical sample processing and testing. ABL is a part of the Institut Mérieux, a group of companies dedicated to developing translational science for better patient care globally.

For more information visit www.ablinc.com or email us.